-
-
-
-
-
-
-
RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests
-
-
-
-
-
-
-
RedHill reports opaganib reduces venetoclax-resistant leukemia cells by 50%
-
-
-
-
-
-
-
RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement
-
-
-
-
-
-
-
RedHill Biopharma wins $10 million court judgment on appeal
-
-
-
-
-
-
-
RedHill gets FDA guidance for Crohn's disease drug trial design
-
-
-
-
-
-
-
RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107
-
-
-
-
-
-
-
RedHill Biopharma to Submit FDA-Approved Talicia® for UK Marketing Authorisation
-
1,160,145 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

